Skip to Main Content

If you are one of the more than 4 billion people around the world who has received a dose of a Covid-19 vaccine, you’ve experienced firsthand the power of collaboration in health care.

Just a few weeks after it became apparent that SARS-CoV-2, the virus that causes Covid-19, was spreading globally, workers from all parts of the health care ecosystem began collaborating. For example, in January 2020 the Jenner Institute and the Oxford Vaccine Group formed a consortium to bring together experts from academia, biotech companies, and development and manufacturing organizations to begin developing the AstraZeneca vaccine, which was authorized for use in the U.K. eleven months later.


It also took Moderna just eleven months to go from an idea for an mRNA-based vaccine to FDA emergency use authorization. The company’s CEO, Stéphane Bancel, thanked people and organizations from all corners of the development process, including clinical trial participants, facilitators, regulatory agencies, governments, suppliers, and partners.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.